Processa Pharmaceuticals Other Current Assets

As of the most recent data (March 2026), PCSA shows a other current assets of $250K. That compares with $860K in the prior-year period — down 71.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PCSA's other current assets is now $250K (was $860K) — a 71.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Processa Pharmaceuticals is outperforming or lagging.

Tracking PCSA's other current assets over time shows whether Processa Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $250K That compares with $860K in the prior-year period — down 71.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Processa Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $250K) with ownership activity and broader fundamentals.

Processa Pharmaceuticals's other current assets is $250K; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.